Zaffaroni M, Ghezzi A, Callea L, Zibetti A
Centro Studi Sclerosi Multipla, Università di Milano Ospedale di Gallarate.
Ital J Neurol Sci. 1992 Nov;13(8):657-60. doi: 10.1007/BF02334969.
We studied the expression of class II MHC product (HLA DR) and IL-2 receptor on circulating monocytes (M phi) in MS patients, neurological and healthy controls, by double color flow cytometry. In all groups most M phi were DR+ without significant differences. More interesting, low percentages of IL-2+ M phi were detectable in healthy and neurological controls, whilst a few MS patients with active disease showed higher levels. This finding is in agreement with similar studies in other T-cell mediated diseases and with the report of rare IL-2+ macrophages in MS plaques. Although the actual role of IL-2+ M phi in the immune response still needs elucidation, our findings suggest their relevance to the pathological process of demyelinating disease.
我们通过双色流式细胞术研究了多发性硬化症(MS)患者、神经系统疾病患者及健康对照者循环单核细胞(M phi)上II类主要组织相容性复合体产物(HLA DR)和白细胞介素-2受体的表达情况。在所有组中,大多数M phi为DR+,无显著差异。更有趣的是,在健康和神经系统疾病对照者中可检测到低比例的IL-2+ M phi,而一些患有活动性疾病的MS患者则显示出较高水平。这一发现与其他T细胞介导疾病的类似研究以及MS斑块中罕见IL-2+巨噬细胞的报道一致。尽管IL-2+ M phi在免疫反应中的实际作用仍需阐明,但我们的发现表明它们与脱髓鞘疾病的病理过程相关。